Committee for Orphan Medicinal Products (COMP): 16-18 June 2020
Date:
16/06/2020 to 18/06/2020
Location:
European Medicines Agency, Amsterdam, the Netherlands
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
-
List item
Minutes of the COMP meeting 16-18 June 2020 (PDF/442.53 KB)
Adopted
First published: 07/08/2020
EMA/COMP/346343/2020 -
List item
COMP meeting report on the review of applications for orphan designation: July 2020 (PDF/124.94 KB)
First published: 23/07/2020
EMA/COMP/382197/2020 -
List item
Agenda - COMP agenda of the 16-18 June 2020 meeting (PDF/273.41 KB)
Draft
First published: 15/06/2020
EMA/COMP/285717/2020